JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasbi, A.
Right arrow Articles by Jauzac, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasbi, A.
Right arrow Articles by Jauzac, P.

Vol. 293, Issue 1, 237-247, April 2000

Internalization and Recycling of delta -Opioid Receptor Are Dependent on a Phosphorylation-Dephosphorylation Mechanism

Ahmed Hasbi, Stéphane Allouche, François Sichel, Laura Stanasila, Dominique Massotte, Gérard Landemore, Jocelyne Polastron and Philippe Jauzac

Laboratoire des Neurosciences, CNRS UMR 6551, Caen, France (A.H., S.A., J.P., P.J.); Laboratoire de Cancérologie Expérimentale, Centre François Baclesse, Caen, France (F.S.); Département des Récepteurs et Protéines Membranaires, CNRS URA 9050, Illkirch Grafenstaden, France (L.S., D.M.); and Laboratoire d'Histologie-Biologie Cellulaire, Faculté de Mèdecine, Caen, France (G.L.)

Internalization, recycling, and resensitization of the human delta -opioid receptor (hDOR) were studied in the neuroblastoma cell line SK-N-BE, endogenously expressing this receptor. Conventional and confocal fluorescence microscopy observations, corroborated by Scatchard analysis, indicated that after a 100 nM Eto treatment, 60 to 70% of hDOR were rapidly internalized (t1/2 < 15 min). This agonist-triggered internalization was reversible for a treatment not exceeding 1 h and became irreversible for prolonged treatment (4 h), leading probably to the degradation and/or down-regulation of the receptor. The rapid internalization of hDOR was totally blocked in the presence of heparin, known as an inhibitor of G protein-coupled receptor kinases (Benovic et al., 1989), a result indicating that phosphorylation by these kinases is a critical step in desensitization (Hasbi et al., 1998) and internalization of hDOR (present study) in SK-N-BE cell line. Blockade of internalization by agents not interferring with phosphorylation, as hypertonic sucrose or concanavalin A, also blocked the resensitization (receptor functional recovering) process. Furthermore, blockade of dephosphorylation of the internalized hDOR by okadaic acid totally suppressed its recycling to the plasma membrane and its subsequent resensitization. These results indicate that regulatory events leading to desensitization, internalization, and recycling in a functional state of hDOR involve phosphorylation by a G protein-coupled receptor kinase, internalization via clathrin-coated vesicles, and dephosphorylation by acid phosphatases.


0022-3565/00/2931-0237$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
F. Wang, X. Chen, X. Zhang, and L. Ma
Phosphorylation State of {micro}-Opioid Receptor Determines the Alternative Recycling of Receptor via Rab4 or Rab11 Pathway
Mol. Endocrinol., August 1, 2008; 22(8): 1881 - 1892.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
G. Mayer, B. Wulffen, C. Huber, J. Brockmann, B. Flicke, L. Neumann, D. Hafenbradl, B. M. Klebl, M. J. Lohse, C. Krasel, et al.
An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro
RNA, March 1, 2008; 14(3): 524 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Qiu, H. H. Loh, and P.-Y. Law
Phosphorylation of the {delta}-Opioid Receptor Regulates Its beta-Arrestins Selectivity and Subsequent Receptor Internalization and Adenylyl Cyclase Desensitization
J. Biol. Chem., August 3, 2007; 282(31): 22315 - 22323.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Navratilova, S. Waite, D. Stropova, M. C. Eaton, I. D. Alves, V. J. Hruby, W. R. Roeske, H. I. Yamamura, and E. V. Varga
Quantitative Evaluation of Human {delta} Opioid Receptor Desensitization Using the Operational Model of Drug Action
Mol. Pharmacol., May 1, 2007; 71(5): 1416 - 1426.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Kenski, C. Zhang, M. von Zastrow, and K. M. Shokat
Chemical Genetic Engineering of G Protein-coupled Receptor Kinase 2
J. Biol. Chem., October 14, 2005; 280(41): 35051 - 35061.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Du and S. R. Post
Macrophage colony-stimulating factor differentially regulates low density lipoprotein and transferrin receptors
J. Lipid Res., September 1, 2004; 45(9): 1733 - 1740.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Lecoq, N. Marie, Ph. Jauzac, and S. Allouche
Different Regulation of Human {delta}-Opioid Receptors by SNC-80 [(+)-4-[({alpha}R)-{alpha}-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and Endogenous Enkephalins
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 666 - 677.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Hasbi, D. Devost, S. A. Laporte, and H. H. Zingg
Real-Time Detection of Interactions between the Human Oxytocin Receptor and G Protein-Coupled Receptor Kinase-2
Mol. Endocrinol., May 1, 2004; 18(5): 1277 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. A. W. Tawfeek and A. B. Abou-Samra
Important role for the V-type H+-ATPase and the Golgi apparatus in the recycling of PTH/PTHrP receptor
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E704 - E710.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. McLaughlin, L. C. Myers, P. E. Zarek, M. G. Caron, R. J. Lefkowitz, T. A. Czyzyk, J. E. Pintar, and C. Chavkin
Prolonged Kappa Opioid Receptor Phosphorylation Mediated by G-protein Receptor Kinase Underlies Sustained Analgesic Tolerance
J. Biol. Chem., January 16, 2004; 279(3): 1810 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
D. Ott, R. Frischknecht, and A. Pluckthun
Construction and characterization of a kappa opioid receptor devoid of all free cysteines
Protein Eng. Des. Sel., January 1, 2004; 17(1): 37 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin
Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization
J. Biol. Chem., September 5, 2003; 278(36): 34631 - 34640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche
Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists
J. Biol. Chem., June 13, 2003; 278(25): 22795 - 22804.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Pan, E. V. Gurevich, and V. V. Gurevich
The Nature of the Arrestin{middle dot}Receptor Complex Determines the Ultimate Fate of the Internalized Receptor
J. Biol. Chem., March 21, 2003; 278(13): 11623 - 11632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. B. Patel, C. N. Patel, V. Rajashekara, and B. C. Yoburn
Opioid Agonists Differentially Regulate {micro}-Opioid Receptors and Trafficking Proteins in Vivo
Mol. Pharmacol., December 1, 2002; 62(6): 1464 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lamey, M. Thompson, G. Varghese, H. Chi, M. Sawzdargo, S. R. George, and B. F. O'Dowd
Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor
J. Biol. Chem., March 8, 2002; 277(11): 9415 - 9421.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. S. G. Ferguson
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. M.-E. Kouhen, G. Wang, J. Solberg, L. J. Erickson, P.-Y. Law, and H. H. Loh
Hierarchical Phosphorylation of delta -Opioid Receptor Regulates Agonist-induced Receptor Desensitization and Internalization
J. Biol. Chem., November 17, 2000; 275(47): 36659 - 36664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Innamorati, C. Le Gouill, M. Balamotis, and M. Birnbaumer
The Long and the Short Cycle. ALTERNATIVE INTRACELLULAR ROUTES FOR TRAFFICKING OF G-PROTEIN-COUPLED RECEPTORS
J. Biol. Chem., April 13, 2001; 276(16): 13096 - 13103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Whistler, P. Tsao, and M. von Zastrow
A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to Lysosomes
J. Biol. Chem., August 31, 2001; 276(36): 34331 - 34338.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.